Recent and Upcoming Therapies for Management of Type 2 Diabetes: A Review
The article encompasses the present and future pharmacotherapies involved in managing type 2 diabetes (T2D). It is divided into three sections: recent treatment modalities of the last decade, upcoming approved drugs to be available in India, and near future drugs under clinical trials. It highlights...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-09-01
|
| Series: | Preventive Medicine: Research & Reviews |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/PMRR.PMRR_12_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849427421482188800 |
|---|---|
| author | Rutul Gokalani Mahira Saiyed Amit Dey Firdous Sheikh |
| author_facet | Rutul Gokalani Mahira Saiyed Amit Dey Firdous Sheikh |
| author_sort | Rutul Gokalani |
| collection | DOAJ |
| description | The article encompasses the present and future pharmacotherapies involved in managing type 2 diabetes (T2D). It is divided into three sections: recent treatment modalities of the last decade, upcoming approved drugs to be available in India, and near future drugs under clinical trials. It highlights the oral hyperglycaemic agents and insulin options available in India, their potential effects on diabetes outcomes and the clinical trials. India is a fast and dynamic adopter of novel treatments and newer technologies with off-patent and in-patent modalities. Medicinal novelties surround T2D, but technological advancements have touched newer heights with surreal support of artificial intelligence-based innovations, especially in type 1 diabetes management. |
| format | Article |
| id | doaj-art-ee0af0db6da348b1a2cb7c7b1a568b4c |
| institution | Kabale University |
| issn | 2950-5828 2950-5836 |
| language | English |
| publishDate | 2024-09-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Preventive Medicine: Research & Reviews |
| spelling | doaj-art-ee0af0db6da348b1a2cb7c7b1a568b4c2025-08-20T03:29:02ZengWolters Kluwer Medknow PublicationsPreventive Medicine: Research & Reviews2950-58282950-58362024-09-011526827210.4103/PMRR.PMRR_12_24Recent and Upcoming Therapies for Management of Type 2 Diabetes: A ReviewRutul GokalaniMahira SaiyedAmit DeyFirdous SheikhThe article encompasses the present and future pharmacotherapies involved in managing type 2 diabetes (T2D). It is divided into three sections: recent treatment modalities of the last decade, upcoming approved drugs to be available in India, and near future drugs under clinical trials. It highlights the oral hyperglycaemic agents and insulin options available in India, their potential effects on diabetes outcomes and the clinical trials. India is a fast and dynamic adopter of novel treatments and newer technologies with off-patent and in-patent modalities. Medicinal novelties surround T2D, but technological advancements have touched newer heights with surreal support of artificial intelligence-based innovations, especially in type 1 diabetes management.https://journals.lww.com/10.4103/PMRR.PMRR_12_24insulinoral hyperglycaemic agentstype 2 diabetesindia |
| spellingShingle | Rutul Gokalani Mahira Saiyed Amit Dey Firdous Sheikh Recent and Upcoming Therapies for Management of Type 2 Diabetes: A Review Preventive Medicine: Research & Reviews insulin oral hyperglycaemic agents type 2 diabetes india |
| title | Recent and Upcoming Therapies for Management of Type 2 Diabetes: A Review |
| title_full | Recent and Upcoming Therapies for Management of Type 2 Diabetes: A Review |
| title_fullStr | Recent and Upcoming Therapies for Management of Type 2 Diabetes: A Review |
| title_full_unstemmed | Recent and Upcoming Therapies for Management of Type 2 Diabetes: A Review |
| title_short | Recent and Upcoming Therapies for Management of Type 2 Diabetes: A Review |
| title_sort | recent and upcoming therapies for management of type 2 diabetes a review |
| topic | insulin oral hyperglycaemic agents type 2 diabetes india |
| url | https://journals.lww.com/10.4103/PMRR.PMRR_12_24 |
| work_keys_str_mv | AT rutulgokalani recentandupcomingtherapiesformanagementoftype2diabetesareview AT mahirasaiyed recentandupcomingtherapiesformanagementoftype2diabetesareview AT amitdey recentandupcomingtherapiesformanagementoftype2diabetesareview AT firdoussheikh recentandupcomingtherapiesformanagementoftype2diabetesareview |